Eurofins-Cerep SA (ALECR) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.043x

Based on the latest financial reports, Eurofins-Cerep SA (ALECR) has a cash flow conversion efficiency ratio of -0.043x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.19 Million ≈ $-3.73 Million USD) by net assets (€73.54 Million ≈ $85.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ALECR net asset quality index to measure how much of total assets are equity-financed.

Eurofins-Cerep SA - Cash Flow Conversion Efficiency Trend (2001–2017)

This chart illustrates how Eurofins-Cerep SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Eurofins-Cerep SA's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Eurofins-Cerep SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Eurofins-Cerep SA ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Ying Han Technology Co Ltd
TW:4562
-0.060x
Apetit Oyj
HE:APETIT
0.118x
Kervansaray Yatirim Holding AS
IS:KERVN
0.067x
NeOnc Technologies Holdings, Inc. Common Stock
NASDAQ:NTHI
0.528x
Hasen-Immobilien AG
STU:ABHA
0.010x
Banco Santander Río S.A
BA:BRIO
-0.322x
Hf Foods Group Inc
NASDAQ:HFFG
0.075x
Oncoinvent ASA
OL:KLDVK
0.013x

Annual Cash Flow Conversion Efficiency for Eurofins-Cerep SA (2001–2017)

The table below shows the annual cash flow conversion efficiency of Eurofins-Cerep SA from 2001 to 2017. For the full company profile with market capitalisation and key ratios, see ALECR company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2017-12-31 €21.31 Million
≈ $24.91 Million
€4.24 Million
≈ $4.95 Million
0.199x -37.92%
2016-12-31 €17.46 Million
≈ $20.41 Million
€5.59 Million
≈ $6.54 Million
0.320x +1002.79%
2015-12-31 €14.97 Million
≈ $17.50 Million
€434.88K
≈ $508.42K
0.029x +116.50%
2014-12-31 €13.16 Million
≈ $15.39 Million
€-2.32 Million
≈ $-2.71 Million
-0.176x -328.97%
2013-12-31 €13.35 Million
≈ $15.60 Million
€1.03 Million
≈ $1.20 Million
0.077x -5.29%
2012-12-31 €13.93 Million
≈ $16.29 Million
€1.13 Million
≈ $1.32 Million
0.081x -68.70%
2011-12-31 €13.57 Million
≈ $15.86 Million
€3.52 Million
≈ $4.11 Million
0.259x +421.40%
2010-12-31 €13.63 Million
≈ $15.94 Million
€-1.10 Million
≈ $-1.29 Million
-0.081x -228.71%
2009-12-31 €18.90 Million
≈ $22.10 Million
€1.19 Million
≈ $1.39 Million
0.063x -72.44%
2008-12-31 €21.47 Million
≈ $25.10 Million
€4.88 Million
≈ $5.71 Million
0.227x +29.62%
2007-12-31 €23.92 Million
≈ $27.96 Million
€4.20 Million
≈ $4.91 Million
0.175x +199.55%
2006-12-31 €14.12 Million
≈ $16.51 Million
€-2.49 Million
≈ $-2.91 Million
-0.176x -391.06%
2005-12-31 €31.13 Million
≈ $36.40 Million
€1.89 Million
≈ $2.20 Million
0.061x -79.31%
2004-12-31 €32.05 Million
≈ $37.47 Million
€9.38 Million
≈ $10.97 Million
0.293x +139.87%
2003-12-31 €29.66 Million
≈ $34.68 Million
€3.62 Million
≈ $4.23 Million
0.122x -16.88%
2002-12-31 €29.32 Million
≈ $34.28 Million
€4.30 Million
≈ $5.03 Million
0.147x +159.56%
2001-12-31 €26.17 Million
≈ $30.60 Million
€1.48 Million
≈ $1.73 Million
0.057x --

About Eurofins-Cerep SA

PA:ALECR France Diagnostics & Research
Market Cap
$96.12 Million
€82.22 Million EUR
Market Cap Rank
#19665 Global
#299 in France
Share Price
€16300.00
Change (1 day)
+0.00%
52-Week Range
€15300.00 - €18600.00
All Time High
€18600.00
About

Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company's research services include compound management, and high-throughput screening and profiling. The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was founded in 1989 and… Read more